US 11370786
GLS1 inhibitors for treating disease
granted A61KA61K31/4192A61K31/433
Quick answer
US patent 11370786 (GLS1 inhibitors for treating disease) held by The Board of Regents of the University of Texas System expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4192, A61K31/433, A61K31/4439, A61K31/444